Santarus, Inc. (NASDAQ: SNTS), today reported financial and operating results for the quarter and year ended December 31, 2012.
Key financial results for the fourth quarter of 2012 include:
• Total revenues of $70.2 million grew 65% compared with $42.6 million for the fourth quarter of 2011
• Net income of $5.5 million, or $0.08 diluted earnings per share (EPS), which included a $10.0 million expense for a success-based clinical milestone, increased significantly compared with $1.9 million, or $0.03 diluted EPS for the fourth quarter of 2011
Key financial results for the fourth quarter of 2012 include:
• Total revenues of $70.2 million grew 65% compared with $42.6 million for the fourth quarter of 2011
• Net income of $5.5 million, or $0.08 diluted earnings per share (EPS), which included a $10.0 million expense for a success-based clinical milestone, increased significantly compared with $1.9 million, or $0.03 diluted EPS for the fourth quarter of 2011
